Cerence Inc. (NASDAQ:CRNC) Q2 2023 Earnings Conference Call May 9, 2023 8:30 AM ET Company Participants Rich Yerganian - SVP-IR Stefan Ortmanns - CEO Tom Beaudoin - CFO Conference Call Participants Jeff Van Rhee - Craig-Hallum Capital Group Colin Langan - Wells Fargo Mark Delaney - Goldman Sachs Operator Good morning, and thank you for standing by. Welcome to the Cerence Second Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will b ...

FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-39030 CERENCE INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of i ...

Cerence Inc. (NASDAQ:CRNC) Q1 2023 Earnings Conference Call February 8, 2023 8:30 AM ET Company Participants Rich Yerganian – Senior Vice President-Investor Relations Stefan Ortmanns – Chief Executive Officer Tom Beaudoin – Chief Financial Officer Conference Call Participants Luke Junk – Baird Colin Langan – Wells Fargo Rajvindra Gill – Needham Jeff Van Rhee – Craig-Hallum Gavin Kennedy – Jefferies Chris McNally – Evercore Mark Delaney – Goldman Sachs Operator Good day and thank you for standing by. Welcome ...

X X | --- | --- | --- | --- | |------------------|-------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | Rich Yerganian, SVP of Investor Relations | | | | | Cerence Q1FY23 February 8, 2023 | | | | | Earnings Presentation | | | | | Stefan Ortmanns, CEO | | | | | | | | | | Tom Beaudoin, CFO | | | | | | | | | | | | | | | | | | | Destination Next | | | | X X Forward-Looking Statements Statements in this presentation regarding: Cerence's future performance, resul ...

FORM 10-Q CERENCE INC. (Exact name of registrant as specified in its charter) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically eve ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Common stock, par value $0.01 per share CRNC The Nasdaq Global Select Market FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ________ Commission File Number: 001-39030 | --- | --- | --- | |---------- ...

| --- | --- | --- | |-------|---------------------------|----------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cerence Q3 FY22 Earnings | | | | Stefan Ortmanns, CEO | | | | | | | | Tom Beaudoin, EVP, CFO | | | | | | | | | | | | Rich Yerganian, SVP of IR | | | | | | | | | | | | | August 9, 2022 | | | © 2022 Cerence Inc. | | Forward-Looking Statements Statements in this release regarding Cerence's future performance, results and financial condition, expected gro ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-39030 CERENCE INC. (Exact name of registrant as specified in its charter) Delaware 83-4177087 (State or othe ...

Cerence Inc. (NASDAQ:CRNC) Q2 2022 Results Conference Call May 10, 2022 8:30 AM ET Company Participants Rich Yerganian - SVP, IR Stefan Ortmanns - CEO Tom Beaudoin - CFO Conference Call Participants David Kelley - Jefferies Jeffrey Van Rhee - Craig Hallum Luke Junk - Baird Mark Delaney - Goldman Sachs Raji Gill - Needham Operator Good day, and thank you for standing by. Welcome to the Cerence Q2 2022 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorde ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-39030 CERENCE INC. (Exact name of registrant as specified in its charter) Delaware 83-4177087 (State or oth ...